Disclosures: Venture Capital Investments 2025/26

The following Venture Capital investments were announced during the fiscal year of 2025/26.

Tuesday, September 23, 2025   
 
Marin X Inc., an aquaculture technology company, operating as Sensor Globe, has secured a venture capital investment of $599,998.83 from Invest Nova Scotia. 

This investment will support the company to enhance its product platforms, increase sales and marketing, and grow its team. 

Sensor Globe combines proprietary hardware and software to deliver monitoring solutions designed to give fish farmers real-time insights during critical operations such as transfers and handling. The company’s sensors and advanced analytics enable farmers to improve fish welfare, reduce risk and fish mortality, and increase operational efficiency.

Invest Nova Scotia invests directly in highly innovative early-stage Nova Scotia companies addressing big challenges – alongside institutional, private sector and angel investors from Canada and beyond. In addition to capital, Invest Nova Scotia provides hands-on business guidance, supports good governance, helps open doors to co-investors, and facilitates relationships across the start-up, technology, and venture capital ecosystems.

Facts:

• Marin X Inc. (Sensor Globe) is located in Dartmouth, Nova Scotia with additional offices in Oslo and Stavanger, Norway.
• The company has also received support through Invest Nova Scotia’s Export Development Program and GreenShoots.
• Invest Nova Scotia manages the Nova Scotia First Fund (NSFF), a venture capital fund investing in pre-seed and seed Nova Scotia-based companies. 

Media Contact:   
Sheamus MacDonald
Co-Founder & CEO 
902.318.0631 
smacdonald@sensorglobe.no

_________________________________

Tuesday, September 9, 2025   
 
Blue Charm Adherence, a health-care technology provider, has secured a venture capital investment of $1 million from Invest Nova Scotia.

This investment will support Blue Charm Adherence as it continues to advance its product offering, grow its patient and customer base, and expand its team.

Blue Charm Adherence provides financial assistance and disease management programs on behalf of the pharmaceutical industry, supporting patients suffering from chronic illnesses. Its proprietary software harnesses real-world patient data around pharmaceutical use in chronic disease to enhance the effectiveness of health-care resources, improve patient outcomes, and empower individuals to take control of their health. Current programs support patients suffering from asthma, severe asthma, IBD, COPD, obesity, and diabetes, with new programs forthcoming.

Invest Nova Scotia invests directly in highly innovative early-stage Nova Scotia companies addressing big challenges – alongside institutional, private sector and angel investors from Canada and beyond. In addition to capital, Invest Nova Scotia provides hands-on business guidance, supports good governance, helps open doors to co-investors, and facilitates relationships across the start-up, technology, and venture capital ecosystems.

Facts:

• Founded in 2020, Blue Charm Adherence is headquartered in Halifax, Nova Scotia.
• Blue Charm Adherence has also received support through Invest Nova Scotia’s Export Development Program.
• Invest Nova Scotia manages the Nova Scotia First Fund (NSFF), a venture capital fund investing in pre-seed and seed Nova Scotia-based companies. 

Media Contact:   
Michael Mailman
902.449.5101
m.mailman@bluecharm.io

_________________________________

Tuesday, September 9, 2025   
 
Novagevity, developer and manufacturer of Sperri, Canada’s first plant-based certified meal replacement beverage, has secured a venture capital investment of $250,000 from Invest Nova Scotia. 

This investment will support Novagevity as it continues to increase distribution and sales of its Sperri brand products. 

Novagevity is a medical nutrition company focused on the design and manufacturing of novel plant-based products for human health. Its flagship product is researched and designed by medical specialists and dieticians to provide optimum nutrients for consumers with specific health conditions. 

Invest Nova Scotia invests directly in highly innovative early-stage Nova Scotia companies addressing big challenges – alongside institutional, private sector and angel investors from Canada and beyond. In addition to capital, Invest Nova Scotia provides hands-on business guidance, supports good governance, helps open doors to co-investors, and facilitates relationships across the start-up, technology, and venture capital ecosystems.

Facts:

• In 2024, Invest Nova Scotia invested $750,000 in Novagevity’s seed round.
• The company has also received support through Invest Nova Scotia’s Greenshoots, Export Development Program, Productivity and Innovation Voucher Program, and Trade Market Intelligence service. Novagevity was formerly a tenant at The Labs at Invest Nova Scotia. 
• Invest Nova Scotia manages the Nova Scotia First Fund (NSFF), a venture capital fund investing in pre-seed and seed Nova Scotia-based companies. 

Media Contact:   
Gregg Curwin
Chief Executive Officer
902.448.1191
gcurwin@novagevity.ca

_________________________________

Tuesday, July 8, 2025   
 
3DBioFibR Inc., a leading manufacturer of advanced biopolymer fibers, has secured a venture capital investment of $1 million from Invest Nova Scotia. 
 
This investment will support 3DBioFibR as it improves operational scale through increased manufacturing capacity, operational growth, and implementation of ISO 13485 certification, including the construction of a clean room manufacturing facility. 
  
3DBioFibR Inc. is driving the adoption of biomaterials in regenerative medicine, medical devices, defence, cosmetics, and sustainable textiles. Its patented dry-spinning technology enables scalable, high-precision manufacturing of advanced biopolymer fibers—delivering superior performance at industrial scales. 
  
Invest Nova Scotia invests directly in highly innovative early-stage Nova Scotia companies addressing big challenges – alongside institutional, private sector, and angel investors from Canada and beyond. In addition to capital, Invest Nova Scotia provides hands-on business guidance, supports good governance, helps open doors to co-investors, and facilitates relationships across the start-up, technology, and venture capital ecosystems. 
  
Facts:

• Invest Nova Scotia invested $100,000 in 3DBioFibR Inc.’s angel round in 2020, $600,000 in a seed round in 2022, and made a $400,000 follow-on investment in 2023.
• 3DBioFibR Inc. has also received support through Invest Nova Scotia’s Early-Stage Commercialization Fund, Export Development Program, and Trade Market Intelligence service. 3DBioFibR is a tenant at The Labs at Invest Nova Scotia.
• Invest Nova Scotia manages the Nova Scotia First Fund (NSFF), a venture capital fund investing in pre-seed and seed Nova Scotia-based companies. 

Media Contact:   
Abrianna Di Pietro
Brand & Office Manager
info@3dbiofibr.com